factual
Suvorexant as an Epic Discovery-Driven Drug Story
The insomnia drug suvorexant exemplifies genuine discovery-driven development: decades of academic research uncovered orexin, a brain chemical that keeps you awake (opposite of melatonin), prompting pharmaceutical companies to hypothesize some insomnia stems from excess orexin binding, screen two million compounds to find a receptor blocker, and run clinical trials costing around a billion dollars over another decade to produce the drug.
factualpending
Speaker
Nicole RustEvidence Quote
“you have decades of academic research, another decade in the pharmaceutical industry, and then you get a drug. It's just a really epic tale of how many people and hours went into the development of that.”
Created: 6/13/2026, 12:22:22 AM
Your notes
Loading notes...